ARKG Holdings of PSNL
Personalis
Personalis, Inc. provides comprehensive genomic sequencing and analytics solutions to support the development of personalized cancer therapies and precision medicine. The company generates revenue by offering its services primarily to pharmaceutical companies and research institutions, enabling advanced biomarker discovery and clinical diagnostics.
Trades of PSNL in ARKG
The ten most recent trades of Personalis in the ARKG ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
|---|---|---|---|---|
| Dec 18, 2024 | Buy | $1,310,924 | 5.60% | 0.11% |
| Dec 17, 2024 | Buy | $249,618 | 1.00% | 0.02% |
| Nov 15, 2024 | Buy | $117,799 | 0.46% | 0.01% |
| Nov 05, 2024 | Sell | $427,466 | 1.26% | 0.04% |
| Sep 11, 2024 | Buy | $2,955,435 | 8.69% | 0.23% |
| Sep 09, 2024 | Buy | $230,440 | 0.74% | 0.02% |
| Jul 10, 2024 | Buy | $7,234 | 0.08% | 0.00% |
| Jul 09, 2024 | Buy | $116,249 | 1.35% | 0.01% |
| Jul 08, 2024 | Buy | $25,541 | 0.27% | 0.00% |
| Apr 11, 2024 | Buy | $36,094 | 0.42% | 0.00% |